Effects of modern chondroprotectors in osteoarthritis
https://doi.org/10.21518/2079-701X-2014-5-92-99
Abstract
Osteoarthritis (OA) unites a group of diseases of the joints of various etiology causing deterioration and gradual loss of the articular cartilage. Osteoarthritis is the highest-ranking disease among the musculoskeletal diseases. According to WHO, osteoarthritis affects more than 4% of the world population, in 10% of cases causing disability, deterioration in the quality of life and social disadaptation of patients.
About the Authors
V. V. Kosarev
Samara State Medical University, Russia's Ministry of Health
Russian Federation
Russian Federation
S. A. Babanov
Samara State Medical University, Russia's Ministry of Health
Russian Federation
Russian Federation
References
1. Котельников Г.П., Ларцев Ю.В. Остеоартроз: М.: Гэотар-Медиа, 2009.
2. Крюков Н.Н., Качковский М.А., Бабанов С.А., Вербовой А.Ф. Справочник терапевта. Ростов н/Д: Феникс, 2013.
3. Светлова М.С. Гонартроз ранних стадий: клинико-инструментальная, лабораторная характеристика и болезнь-модифицирующая терапия. Автореф. дисс. д-ра мед. наук. Ярославль, 2009.
4. Алексеева Л.И., Шарапова Е.П. Комбинированные симптоматические препараты замедленного действия в терапии остеоартроза. РМЖ, 2009, 17 (4).
5. Алексеева Л.И. Комбинированные препараты в лечении остеоартроза. Медицинский совет, 2012, 8.
6. Насонова В.А. Остеоартроз - проблема полиморбидности. Consilium medicum, 2009, 1: 5-8.
7. Коваленко В.Н., Борткевич О.П. Остеоартроз. Практическое руководство. 2-е изд., перераб. и доп. К.: Морион, 2005.
8. Volpi N. Chondroitin sulfate for the treatment osteoarthritis? Curr. Med. Chem, 2005, 4: 221-34.
9. Чичасова Н.В. Хондроитин сульфат (Структум) в лечении остеоартроза: патогенетическое действие и клиническая эффективность. РМЖ, 2009, 17 (3).
10. НосЫх^ M. Structure effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trial of 2-year duration. Osteoarthritis Cartilage, 2010, 18: 28-31.
11. Zhang W, Nuki G,Moskowitz RW, et al. OARSI recomendations for the management of hip and knee osteoarthritis. Part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage, 2010, 18: 476-99.
12. Schneider H., Maheu E., Cucherat M. Symptom-Modifying Effect of Chondroitin Sulfate in Knee Osteoarthritis: A Meta-Analysis of Randomized Placebo-Controlled Trials Performed with Structum®. Open Rheumatol. J, 2012, 6: 183-189.
13. ^han A. et al. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: The study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum., 2009, 60 (2): 524-533.
14. Towheed TE, Maxwell L. Anastassiades TP et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database of Systematic Reviews, 2005.
15. Pavelka K, Gatterova J, Olejarova M et al. Glucosamine sulphatе use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med, 2002, 162 (18): 2113-23.
16. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet, 2001, 357 (9252): 251-6.
17. Lippielo L, Woodword J, Karpman D et al. Beneficial effect of cartilage structure modyifing agents tested in chondrocyte and rabbit instability model osteoartrosis. Arthr. Rheum, 1999, suppl. 42: 256.
18. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and metaanalysis. JAMA, 2000, 283 (11): 1469-1475.
19. Das A. Jr., Hammad T.A. Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage, 2000, Sep., 8 (5): 343-350.
20. Алексеева Л.И., Кашеварова Н.Г, Шарапова Е.П., Зайцева Е.М., Северинова М.В. Сравнение постоянного и интермиттирующего лечения больных остеоартрозом коленных суставов комбинированным препаратом «Терафлекс». Научно-практическая ревматология, 2008, 3: 68-72.
21. Arthritis Research UK 2013, Osteoarthritis in general practice.
Review
For citations:
Kosarev VV, Babanov SA. Effects of modern chondroprotectors in osteoarthritis. Meditsinskiy sovet = Medical Council. 2014;(5):92-99. (In Russ.) https://doi.org/10.21518/2079-701X-2014-5-92-99
Views:
477
Email this article 